InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
2
T+90 hit rate
22%
T+90 mean return
-13.8%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Stilwell McDavid. Officer active across 1 company, notably Coherus BioSciences, Inc.. In total, 11 filings have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €183k. Activity tracked since 9 June 2021. The latest transaction was filed on 31 December 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations11 total
18,440 shares@ US$3.3315.8% of flowCommon StockSEC:0001610717-24-000001:0
3,457 shares@ US$6.846.2% of flowCommon StockSEC:0001140361-23-016453:0
40,000 shares0Common StockSEC:0001567619-23-001207:0
5,437 shares@ US$9.8714.5% of flowCommon StockSEC:0001567619-23-000695:0
3,458 shares@ US$12.850.023% mcap18.0% of flowCommon StockSEC:0001567619-22-008114:0
40,000 shares0Common StockSEC:0001567619-22-000820
40,000 shares0Common StockSEC:0001567619-22-000820:0
3,507 shares@ US$16.80030.030% mcap22.8% of flowCommon StockSEC:0001567619-21-018470:0
3,507 shares@ US$16.800314.5% of flowCommon StockSEC:0001567619-21-018470
3,700 shares@ US$13.42370.024% mcap18.3% of flowCommon StockSEC:0001567619-21-011972:0
Ideal exit: 6 Mar 2022 (T+270)
3,700 shares@ US$13.423711.6% of flowCommon StockSEC:0001567619-21-011972
Ideal exit: 6 Mar 2022 (T+270)
11 of 11 declarations
About Stilwell McDavid
Stilwell McDavid is a director at Coherus BioSciences, Inc.
